Amgen Inc. et al v. Hospira, Inc. et al > Documents

Date Field	Doc. No.	Description (Pages)
Sep 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [332] Stipulation of Dismissal filed by Amgen Inc., Amgen Manufacturing, Limited, (CASE CLOSED). Signed by Judge Colm F. Connolly on 9/8/2021. (nmf)
Sep 8, 2021	333	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,643,997. (nmf)
Sep 1, 2021	332	Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal With Prejudice by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Aug 26, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [330] STIPULATION TO EXTEND TIME to File Redacted Versions of the Proposed Pre-Trial Order and Exhibits 1-18 to September 9, 2021 filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 8/26/2021. (nmf)
Aug 26, 2021	330	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File Redacted Versions of the Proposed Pre-Trial Order and Exhibits 1-18 to September 9, 2021 - filed by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Aug 26, 2021	331	Redacted Document (12) Docket Text: REDACTED VERSION of [329] Reply Brief, by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Aug 20, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings: The Final Pretrial Conference is rescheduled for 9/17/2021 immediately following the Markman Hearing in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 8/20/2021. (nmf)
Aug 20, 2021	325	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Notice Pursuant to 35 U.S.C. � 282(c) filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Aug 20, 2021	326	Letter (9) Docket Text: Letter to The Honorable Colm F. Connolly from Arthur G. Connolly III regarding Letter Brief Regarding the Meaning of the Term "Refold" in Claim 9 of U.S. Patent No. 9,643,997 - re [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997. (Connolly, Arthur)
Aug 20, 2021	327	Declaration (Main Document) (2) Docket Text: DECLARATION re [326] Letter, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibits A-F)(Connolly, Arthur)
Aug 20, 2021	327	Declaration (Exhibits A-F) (30) Docket Text: DECLARATION re [326] Letter, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibits A-F)(Connolly, Arthur)
Aug 20, 2021	328	Letter (Main Document) (9) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Certificate of Compliance) (1) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Affidavit Supplemental Declaration of Richard C. Willson, Ph.D.) (9) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 1) (6) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 2) (5) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 3) (7) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 4) (8) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 5) (5) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 6) (7) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 7) (6) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 8) (14) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 9) (14) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 10) (12) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 11) (30) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 12) (6) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 13) (14) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 14) (5) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 15) (9) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 16) (30) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 17) (13) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 20, 2021	328	Letter (Exhibit 18) (25) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Construction of Refold in the 997 Patent. (Attachments: # (1) Certificate of Compliance, # (2) Affidavit Supplemental Declaration of Richard C. Willson, Ph.D., # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13, # (16) Exhibit 14, # (17) Exhibit 15, # (18) Exhibit 16, # (19) Exhibit 17, # (20) Exhibit 18)(Mowery, Katharine)
Aug 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [321] STIPULATION to extend time for Plaintiffs to submit public redacted versions of the Reply Brief in Further Support of Motion to Strike and the Declaration of Jennifer Wu in Support of Reply Brief in Further Support of Motion to Strike with [Proposed] Order by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 8/19/2021. (nmf)
Aug 19, 2021	323	Redacted Document (14) Docket Text: REDACTED VERSION of [313] Reply Brief, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Exhibit H) (10) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Exhibit I) (3) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Exhibit J) (14) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Exhibit K) (7) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 19, 2021	324	Redacted Document (Exhibit L) (3) Docket Text: REDACTED VERSION of [314] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit H, # (2) Exhibit I, # (3) Exhibit J, # (4) Exhibit K, # (5) Exhibit L)(Cragg, Tyler)
Aug 18, 2021	321	Stipulation (2) Docket Text: STIPULATION to extend time for Plaintiffs to submit public redacted versions of the Reply Brief in Further Support of Motion to Strike and the Declaration of Jennifer Wu in Support of Reply Brief in Further Support of Motion to Strike with [Proposed] Order by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Aug 13, 2021	319	Notice (Other) (2) Docket Text: NOTICE of the Withdrawal of Brandon R. Harper as Counsel of Record by Hospira, Inc., Pfizer Inc. (Connolly, Arthur)
Aug 12, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of D.I. [315] as well as the pdfs of the Exhibits to D.I. [316] and D.I. [318] have been replaced with corrected versions per request of filer. (nmf)
Aug 11, 2021	315	Redacted Document (18) Docket Text: REDACTED VERSION of [303] Response to Motion, by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur) (Main Document 315 replaced on 8/12/2021) (nmf, ).
Aug 11, 2021	316	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [304] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to M)(Connolly, Arthur) (Attachment 1 replaced on 8/12/2021) (nmf, ).
Aug 11, 2021	316	Redacted Document (Exhibit A to M) (30) Docket Text: REDACTED VERSION of [304] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to M)(Connolly, Arthur) (Attachment 1 replaced on 8/12/2021) (nmf, ).
Aug 11, 2021	317	Redacted Document (Main Document) (18) Docket Text: REDACTED VERSION of [305] MOTION for Leave to File Amended Answer to Amgen's First Amended and Supplemental Complaint by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Connolly, Arthur)
Aug 11, 2021	317	Redacted Document (Exhibit 1) (30) Docket Text: REDACTED VERSION of [305] MOTION for Leave to File Amended Answer to Amgen's First Amended and Supplemental Complaint by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Connolly, Arthur)
Aug 11, 2021	317	Redacted Document (Exhibit 2) (30) Docket Text: REDACTED VERSION of [305] MOTION for Leave to File Amended Answer to Amgen's First Amended and Supplemental Complaint by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Connolly, Arthur)
Aug 11, 2021	318	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [306] Declaration, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to N)(Connolly, Arthur) (Attachment 1 replaced on 8/12/2021) (nmf, ).
Aug 11, 2021	318	Redacted Document (Exhibit A to N) (30) Docket Text: REDACTED VERSION of [306] Declaration, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to N)(Connolly, Arthur) (Attachment 1 replaced on 8/12/2021) (nmf, ).
Aug 10, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text of D.I. [310] has been modified per request of filer to reflect that it is a proposed jury verdict form. (nmf)
Aug 6, 2021	312	Order (3) Docket Text: ORDER re [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 filed by Hospira, Inc., Pfizer Inc. A Hearing is set for 9/17/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. The parties may submit no later than August 20, 2021 letter briefs of no more than 3,000 words. See order for further details and deadlines. Signed by Judge Colm F. Connolly on 8/6/2021. (fms)
Aug 5, 2021	307	Order on Motion for Partial Summary Judgment (2) Docket Text: ORDER denying [207] Motion for Partial Summary Judgment. Signed by Judge Colm F. Connolly on 8/5/2021. (fms)
Aug 5, 2021	308	Proposed Voir Dire (7) Docket Text: Proposed Voir Dire by Amgen Inc., Amgen Manufacturing, Limited. (Whetzel, Robert)
Aug 5, 2021	309	Verdict Sheet (6) Docket Text: VERDICT SHEET by Amgen Inc., Amgen Manufacturing, Limited [Proposed]. (Whetzel, Robert)
Aug 5, 2021	310	Proposed Voir Dire (7) Docket Text: Proposed Jury Verdict Form by Hospira, Inc., Pfizer Inc. (Connolly, Arthur) Modified on 8/10/2021 (nmf).
Aug 5, 2021	311	Proposed Jury Instructions (30) Docket Text: Proposed Jury Instructions by Amgen Inc., Amgen Manufacturing, Limited . (Whetzel, Robert)
Aug 3, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [302] MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Klein filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 8/3/2021. (fms)
Aug 3, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel J. Klein for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
Aug 2, 2021	302	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Klein - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Jul 30, 2021	301	Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance of Stephanie S. Riley by Hospira, Inc., Pfizer Inc. (Connolly, Arthur)
Jul 21, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of Exhibit F to the Declaration filed at D.I. [300] has been replaced with a corrected version per request of counsel. (nmf)
Jul 20, 2021	299	Motion to Strike (Main Document) (13) Docket Text: MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Certificate of Compliance, # (2) D. Del. LR 7.1.1 Certification)(Whetzel, Robert)
Jul 20, 2021	299	Motion to Strike (Certificate of Compliance) (1) Docket Text: MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Certificate of Compliance, # (2) D. Del. LR 7.1.1 Certification)(Whetzel, Robert)
Jul 20, 2021	299	Motion to Strike (D. Del. LR 7.1.1 Certification) (1) Docket Text: MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Certificate of Compliance, # (2) D. Del. LR 7.1.1 Certification)(Whetzel, Robert)
Jul 20, 2021	300	Declaration (Main Document) (2) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit A) (6) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit B) (7) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit C) (4) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit D) (3) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit E) (5) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit F) (5) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 20, 2021	300	Declaration (Exhibit G) (17) Docket Text: DECLARATION re [299] MOTION to Strike Hospira's Newly-Asserted Prior-Commercial-Use Defense Under 35 U.S.C. Section 273 by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Whetzel, Robert) (Attachment 6 replaced on 7/21/2021) (nmf, ).
Jul 2, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shannon Lane for Hospira, Inc. and for Pfizer Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jul 1, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [298] MOTION for Pro Hac Vice Appearance of Attorney Shannon Lane filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 7/1/2021. (fms)
Jun 30, 2021	298	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon Lane - filed by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Jun 16, 2021	297	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Supplemental Expert Report of Ryan Sullivan, Ph.D. filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
May 20, 2021	296	Memorandum and Order (3) Docket Text: MEMORANDUM ORDER denying [205] MOTION for Summary Judgment of Noninfringement of the ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 5/20/2021. (nmf)
Apr 8, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Exhibits 1-7 have been added to the Redacted Document at D.I. [290] per request of counsel. (nmf)
Apr 7, 2021	294	Redacted Document (13) Docket Text: REDACTED VERSION of [228] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Apr 7, 2021	295	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [229] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-3)(Cragg, Tyler)
Apr 7, 2021	295	Redacted Document (Exhibit 1-3) (30) Docket Text: REDACTED VERSION of [229] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-3)(Cragg, Tyler)
Mar 31, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Exhibits 1-3 have been added to the Redacted Declaration at D.I. [280] per request of counsel.(nmf)
Mar 30, 2021	256	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [205] MOTION for Summary Judgment of Noninfringement of the ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	256	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [205] MOTION for Summary Judgment of Noninfringement of the ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	257	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	257	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	258	Redacted Document (24) Docket Text: REDACTED VERSION of [213] Opening Brief in Support, by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	259	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [215] MOTION Daubert Motion to Exclude the Opinions and Testimony of Jonathan Garen by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	259	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [215] MOTION Daubert Motion to Exclude the Opinions and Testimony of Jonathan Garen by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	260	Redacted Document (10) Docket Text: REDACTED VERSION of [216] Opening Brief in Support, by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	261	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [218] MOTION Daubert Motion to Exclude Opinions and Testimony of Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	261	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [218] MOTION Daubert Motion to Exclude Opinions and Testimony of Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order)(Riley, Stephanie)
Mar 30, 2021	262	Redacted Document (14) Docket Text: REDACTED VERSION of [238] Reply Brief by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	263	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [239] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit K to O)(Riley, Stephanie)
Mar 30, 2021	263	Redacted Document (Exhibit K to O) (30) Docket Text: REDACTED VERSION of [239] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit K to O)(Riley, Stephanie)
Mar 30, 2021	264	Redacted Document (9) Docket Text: REDACTED VERSION of [245] Reply Brief by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	265	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [246] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit B)(Riley, Stephanie)
Mar 30, 2021	265	Redacted Document (Exhibit B) (6) Docket Text: REDACTED VERSION of [246] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit B)(Riley, Stephanie)
Mar 30, 2021	266	Redacted Document (23) Docket Text: REDACTED VERSION of [206] Opening Brief in Support, by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	267	Redacted Document (Main Document) (11) Docket Text: REDACTED VERSION of [214] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of Elizabeth Chang, # (2) Exhibit A-J)(Connolly, Arthur)
Mar 30, 2021	267	Redacted Document (Declaration of Elizabeth Chang) (3) Docket Text: REDACTED VERSION of [214] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of Elizabeth Chang, # (2) Exhibit A-J)(Connolly, Arthur)
Mar 30, 2021	267	Redacted Document (Exhibit A-J) (30) Docket Text: REDACTED VERSION of [214] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of Elizabeth Chang, # (2) Exhibit A-J)(Connolly, Arthur)
Mar 30, 2021	268	Redacted Document (Main Document) (14) Docket Text: REDACTED VERSION of [210] Statement, in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) PUBLIC VERSION of Declaration of Kevin Georgek, # (2) Exhibit A to T)(Riley, Stephanie)
Mar 30, 2021	268	Redacted Document (PUBLIC VERSION of Declaration of Kevin Georgek) (4) Docket Text: REDACTED VERSION of [210] Statement, in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) PUBLIC VERSION of Declaration of Kevin Georgek, # (2) Exhibit A to T)(Riley, Stephanie)
Mar 30, 2021	268	Redacted Document (Exhibit A to T) (30) Docket Text: REDACTED VERSION of [210] Statement, in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) PUBLIC VERSION of Declaration of Kevin Georgek, # (2) Exhibit A to T)(Riley, Stephanie)
Mar 30, 2021	269	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [217] Declaration, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A)(Connolly, Arthur)
Mar 30, 2021	269	Redacted Document (Exhibit A) (26) Docket Text: REDACTED VERSION of [217] Declaration, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A)(Connolly, Arthur)
Mar 30, 2021	270	Redacted Document (20) Docket Text: REDACTED VERSION of [219] Opening Brief in Support, Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	271	Redacted Document (17) Docket Text: REDACTED VERSION of [223] Answering Brief in Opposition, by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Mar 30, 2021	272	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [220] Declaration, in Support of Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to L)(Riley, Stephanie)
Mar 30, 2021	272	Redacted Document (Exhibit A to L) (30) Docket Text: REDACTED VERSION of [220] Declaration, in Support of Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A to L)(Riley, Stephanie)
Mar 30, 2021	273	Redacted Document (14) Docket Text: REDACTED VERSION of [240] Reply Brief, in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	274	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [224] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A-C)(Connolly, Arthur)
Mar 30, 2021	274	Redacted Document (Exhibit A-C) (30) Docket Text: REDACTED VERSION of [224] Declaration by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A-C)(Connolly, Arthur)
Mar 30, 2021	275	Redacted Document (30) Docket Text: REDACTED VERSION of [226] Answering Brief in Opposition, by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Mar 30, 2021	276	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [241] Declaration in Support of Reply Brief in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit U to DD)(Riley, Stephanie)
Mar 30, 2021	276	Redacted Document (Exhibit U to DD) (30) Docket Text: REDACTED VERSION of [241] Declaration in Support of Reply Brief in Support of Motion for Summary Judgment - Noninfringement by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit U to DD)(Riley, Stephanie)
Mar 30, 2021	277	Redacted Document (12) Docket Text: REDACTED VERSION of [243] Reply Brief in Support of Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 30, 2021	278	Redacted Document (12) Docket Text: REDACTED VERSION of [203] MOTION Daubert Motion To Exclude The Opinion of Hospira's Expert Dr. Bogenstaetter That The Sale Of Rights Is Equivalent To The Sale Of A Product Itself by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	279	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [244] Declaration in Support of Reply Brief ISO Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit M)(Riley, Stephanie)
Mar 30, 2021	279	Redacted Document (Exhibit M) (12) Docket Text: REDACTED VERSION of [244] Declaration in Support of Reply Brief ISO Motion to Exclude Dr. Ryan Sullivan by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit M)(Riley, Stephanie)
Mar 30, 2021	280	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [204] Declaration, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler) (Additional attachment(s) added on 3/31/2021: # (1) Exhibits 1-3) (nmf, ).
Mar 30, 2021	280	Redacted Document (Exhibits 1-3) (30) Docket Text: REDACTED VERSION of [204] Declaration, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler) (Additional attachment(s) added on 3/31/2021: # (1) Exhibits 1-3) (nmf, ).
Mar 30, 2021	281	Redacted Document (30) Docket Text: REDACTED VERSION of [208] Opening Brief in Support, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	282	Redacted Document (10) Docket Text: REDACTED VERSION of [209] Statement, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	283	Redacted Document (Main Document) (13) Docket Text: REDACTED VERSION of [230] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of A. Hanstead, # (2) Exhibit A - G, # (3) Exhibit H - JJ)(Connolly, Arthur)
Mar 30, 2021	283	Redacted Document (Declaration of A. Hanstead) (6) Docket Text: REDACTED VERSION of [230] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of A. Hanstead, # (2) Exhibit A - G, # (3) Exhibit H - JJ)(Connolly, Arthur)
Mar 30, 2021	283	Redacted Document (Exhibit A - G) (30) Docket Text: REDACTED VERSION of [230] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of A. Hanstead, # (2) Exhibit A - G, # (3) Exhibit H - JJ)(Connolly, Arthur)
Mar 30, 2021	283	Redacted Document (Exhibit H - JJ) (30) Docket Text: REDACTED VERSION of [230] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Declaration of A. Hanstead, # (2) Exhibit A - G, # (3) Exhibit H - JJ)(Connolly, Arthur)
Mar 30, 2021	284	Redacted Document (Main Document) (11) Docket Text: REDACTED VERSION of [211] Declaration, by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-25)(Cragg, Tyler)
Mar 30, 2021	284	Redacted Document (Exhibit 1-25) (30) Docket Text: REDACTED VERSION of [211] Declaration, by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-25)(Cragg, Tyler)
Mar 30, 2021	285	Redacted Document (19) Docket Text: REDACTED VERSION of [225] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	286	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [227] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-7)(Cragg, Tyler)
Mar 30, 2021	286	Redacted Document (Exhibit 1-7) (30) Docket Text: REDACTED VERSION of [227] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-7)(Cragg, Tyler)
Mar 30, 2021	287	Redacted Document (18) Docket Text: REDACTED VERSION of [231] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	288	Redacted Document (7) Docket Text: REDACTED VERSION of [232] Statement by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	289	Redacted Document (Main Document) (9) Docket Text: REDACTED VERSION of [233] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-8)(Cragg, Tyler)
Mar 30, 2021	289	Redacted Document (Exhibit 1-8) (30) Docket Text: REDACTED VERSION of [233] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-8)(Cragg, Tyler)
Mar 30, 2021	290	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [236] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler) (Additional attachment(s) added on 4/8/2021: # (1) Exhibits 1-7) (nmf, ).
Mar 30, 2021	290	Redacted Document (Exhibits 1-7) (30) Docket Text: REDACTED VERSION of [236] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler) (Additional attachment(s) added on 4/8/2021: # (1) Exhibits 1-7) (nmf, ).
Mar 30, 2021	291	Redacted Document (13) Docket Text: REDACTED VERSION of [242] Reply Brief, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	292	Redacted Document (22) Docket Text: REDACTED VERSION of [247] Reply Brief, by Amgen Inc., Amgen Manufacturing, Limited. (Cragg, Tyler)
Mar 30, 2021	293	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [248] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 26-30)(Cragg, Tyler)
Mar 30, 2021	293	Redacted Document (Exhibit 26-30) (30) Docket Text: REDACTED VERSION of [248] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 26-30)(Cragg, Tyler)
Mar 29, 2021	255	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to Second Set of Requests for Admission (Nos. 21-460) filed by Amgen Inc., Amgen Manufacturing, Limited.(Cragg, Tyler)
Mar 25, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [254] STIPULATION TO EXTEND TIME to File the Public Versions of all Summary Judgment and Daubert Submissions to March 30, 2021 filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 3/25/2021. (fms)
Mar 24, 2021	254	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to File the Public Versions of all Summary Judgment and Daubert Submissions to March 30, 2021 - filed by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 22, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the Exhibits to the Sealed Declaration at D.I. [227] has been replaced with a corrected version per request of counsel to include exhibits that contain the highlighting. (nmf)
Mar 17, 2021	252	Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Hospira, Inc., Pfizer Inc. re [207] MOTION for Partial Summary Judgment of No Invalidity of the '997 Patent Under the Prior Knowledge and Use Provisions of 35 U.S.C. Section 102(a) and Section 102(b), [218] MOTION Daubert Motion to Exclude Opinions and Testimony of Dr. Ryan Sullivan, [205] MOTION for Summary Judgment of Noninfringement of the ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997, [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997. (Riley, Stephanie)
Mar 17, 2021	253	Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Mar 16, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [251] STIPULATION TO EXTEND TIME to File the Public Versions of all Summary Judgment and Daubert Submissions to March 24, 2021 filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 3/16/2021. (fms)
Mar 16, 2021	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 3/16/2021. (Court Reporter V. Gunning.) (nmf)
Mar 16, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER Resetting Scheduling Order Deadlines: (The Joint Proposed Jury Instructions are due by 8/5/2021., The Proposed Pretrial Order is due by 8/19/2021., The Final Pretrial Conference is rescheduled for 9/9/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., The Jury Trial is rescheduled to begin 9/20/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 3/16/2021. (nmf)
Mar 16, 2021	251	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to File the Public Versions of all Summary Judgment and Daubert Submissions to March 24, 2021 - filed by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Mar 12, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference re [250] Letter: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers.( A Telephone Conference is set for 3/16/2021 at 03:30 PM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 3/12/2021. (nmf)
Mar 11, 2021	249	SO ORDERED (2) Docket Text: SO ORDERED, re [237] STIPULATION TO EXTEND TIME filed by Amgen Inc., Amgen Manufacturing, Limited. Proposed Pretrial Order due by 4/15/2021. See stipulation for further details and deadlines. Signed by Judge Colm F. Connolly on 3/11/2021. (fms)
Mar 11, 2021	250	Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Parties Request for Trial Continuance. (Whetzel, Robert)
Mar 8, 2021	237	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME 1) Plaintiffs to serve Defendants draft pretrial order; 2) Defendants to serve response to Plaintiffs' draft pretrial order; and 3) the parties to file proposed pretrial order with the Court to March 16, 2021; April 1, 2021; and April 15, 2021 respectively - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Mar 3, 2021	234	Answering Brief in Opposition (Main Document) (23) Docket Text: ANSWERING BRIEF in Opposition re [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 filed by Amgen Inc., Amgen Manufacturing, Limited.Reply Brief due date per Local Rules is 3/10/2021. (Attachments: # (1) Certificate of Compliance)(Whetzel, Robert)
Mar 3, 2021	234	Answering Brief in Opposition (Certificate of Compliance) (1) Docket Text: ANSWERING BRIEF in Opposition re [212] MOTION for Summary Judgment OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 9,643,997 filed by Amgen Inc., Amgen Manufacturing, Limited.Reply Brief due date per Local Rules is 3/10/2021. (Attachments: # (1) Certificate of Compliance)(Whetzel, Robert)
Mar 3, 2021	235	Statement (Main Document) (6) Docket Text: STATEMENT re [234] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Certificate of Compliance)(Whetzel, Robert)
Mar 3, 2021	235	Statement (Certificate of Compliance) (1) Docket Text: STATEMENT re [234] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Certificate of Compliance)(Whetzel, Robert)
Mar 1, 2021	222	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Requests for Admission to Plaintiffs (Nos. 21-460) filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Feb 24, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Rebecca E. Fett for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Feb 24, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [221] STIPULATION TO EXTEND TIME Public Versions of all Summary Judgment and Daubert Submissions to March 17, 2021 filed by Hospira, Inc., Pfizer Inc. Ordered by Judge Colm F. Connolly on 2/24/2021. (fms)
Feb 23, 2021	221	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Public Versions of all Summary Judgment and Daubert Submissions to March 17, 2021 - filed by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Feb 19, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney J. Drew Diamond for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Feb 18, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [202] MOTION for Pro Hac Vice Appearance of Attorney J Drew Diamond filed by Amgen Inc., Amgen Manufacturing, Limited Signed by Judge Colm F. Connolly on 2/18/2021. (fms)
Feb 18, 2021	N/A	Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [218] MOTION Daubert Motion to Exclude Opinions and Testimony of Dr. Ryan Sullivan, [215] MOTION Daubert Motion to Exclude the Opinions and Testimony of Jonathan Garen, [203] MOTION Daubert Motion To Exclude The Opinion of Hospira's Expert Dr. Bogenstaetter That The Sale Of Rights Is Equivalent To The Sale Of A Product Itself (fms)
Feb 17, 2021	202	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J Drew Diamond - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Feb 17, 2021	207	Motion for Partial Summary Judgment (Main Document) (2) Docket Text: MOTION for Partial Summary Judgment of No Invalidity of the '997 Patent Under the Prior Knowledge and Use Provisions of 35 U.S.C. Section 102(a) and Section 102(b) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order)(Whetzel, Robert)
Feb 17, 2021	207	Motion for Partial Summary Judgment (Text of Proposed Order) (2) Docket Text: MOTION for Partial Summary Judgment of No Invalidity of the '997 Patent Under the Prior Knowledge and Use Provisions of 35 U.S.C. Section 102(a) and Section 102(b) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order)(Whetzel, Robert)
Feb 12, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Subpoena previously found at D.I. 200 has been deleted per request of filer as it was filed in this case in error. (nmf)
Feb 12, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [201] MOTION for Pro Hac Vice Appearance of Attorney Rebecca Fett filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 2/12/2021. (fms)
Feb 11, 2021	201	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Rebecca Fett - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Feb 9, 2021	199	Notice (Other) (3) Docket Text: NOTICE of VIDEO DEPOSITION of Todd Przybycien on February 11, 2021 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Feb 1, 2021	196	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Alois Jungbauer on February 4, 2021 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Feb 1, 2021	197	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Johnathan Garen on February 5, 2021 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Feb 1, 2021	198	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Harvey Blanch on February 8, 2021 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 29, 2021	195	Notice (Other) (3) Docket Text: NOTICE of Video Deposition of Michael Bogenstaetter on February 2, 2021 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Jan 25, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [193] MOTION for Pro Hac Vice Appearance of Attorney Jaclyn Phillips filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 1/25/2021. (fms)
Jan 25, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jaclyn Phillips for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Jan 25, 2021	193	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jaclyn Phillips - filed by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Jan 25, 2021	194	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' (i) Rebuttal Expert Report of Dr. Michael Bogenstaetter; (ii) Supplemental Reply Expert Report of Alois Jungbauer, Ph.D.; and (iii) Supplemental Reply Expert Report of Todd Przybycien, Ph.D. filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Jan 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [192] Stipulation filed by Hospira, Inc., Pfizer Inc.. Ordered by Judge Colm F. Connolly on 1/20/2021. (fms)
Jan 19, 2021	192	Stipulation (6) Docket Text: STIPULATION Concerning Settlement, License, and Confidentiality Agreements from IPR2019-01183 by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
Jan 8, 2021	191	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Responsive Expert Report of Harvey W. Blanch Ph.D. Regarding Validity of U.S. Patent No. 9,643,997; and (2) Opening Expert Report of Jonathan Garen filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Dec 28, 2020	190	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Eric Agovino as co-counsel.. (Mowery, Katharine)
Dec 23, 2020	189	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Pfizer's Supplemental Responses to Amgen's Second Set of Interrogatories; (ii) Pfizer's Second Supplemental Responses to Amgen's First Set of Interrogatories; and (iii) Pfizer's Second Supplemental Invalidity Contentions filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Dec 22, 2020	188	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Third Supplemental Objections and Responses to Defendants' Interrogatory No. 8 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Dec 16, 2020	185	Notice (Other) (3) Docket Text: NOTICE of Video Deposition of Mirela Bubenik by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Dec 16, 2020	186	Notice (Other) (10) Docket Text: NOTICE of Video Deposition of Celerion, Inc. by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Dec 16, 2020	187	Notice (Other) (11) Docket Text: NOTICE of Video Deposition of SRI International by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Dec 7, 2020	184	Notice (Other) (3) Docket Text: Amended NOTICE of Video Deposition of Domagoj Runac on December 9, 2020 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Nov 23, 2020	182	Stipulation (15) Docket Text: STIPULATION Concerning Protocol for Conducting Remote Depositions by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Nov 23, 2020	183	SO ORDERED (15) Docket Text: SO ORDERED, re [182] Stipulation filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 11/23/2020. (fms)
Nov 19, 2020	181	Notice (Other) (3) Docket Text: Amended NOTICE of Video Deposition of Goran Valinger by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Oct 30, 2020	179	Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur)
Oct 30, 2020	180	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Supplemental 30(b)(6) Notice filed by Hospira, Inc., Pfizer Inc..(Harper, Brandon)
Oct 8, 2020	177	Subpoena Returned Executed (1) Docket Text: SUBPOENA Returned Executed as to [Subpoena to Testify] on SRI International on September 29, 2020 (Mowery, Katharine)
Oct 8, 2020	178	Subpoena Returned Executed (1) Docket Text: SUBPOENA Returned Executed as to [Subpoena to Produce Documents] to SRI International on September 29, 2020 (Mowery, Katharine)
Sep 30, 2020	174	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Notice of Video Deposition of Hospira, Inc. and Pfizer Inc. Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Sep 30, 2020	175	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Goran Valinger Pursuant to Rule 30(b)(1) of the Federal Rules of Civil Procedure on November 17, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Sep 30, 2020	176	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Domagoj Runac Pursuant to Rule 30(b)(1) of the Federal Rules of Civil Procedure on December 4, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Sep 28, 2020	170	Notice (Other) (Main Document) (3) Docket Text: NOTICE of Subpoenas on Celerion Inc. by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	170	Notice (Other) (Exhibit 1) (30) Docket Text: NOTICE of Subpoenas on Celerion Inc. by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	170	Notice (Other) (Exhibit 2) (30) Docket Text: NOTICE of Subpoenas on Celerion Inc. by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	171	Notice (Other) (Main Document) (3) Docket Text: NOTICE of Subpoenas on SRI International by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	171	Notice (Other) (Exhibit 1) (30) Docket Text: NOTICE of Subpoenas on SRI International by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	171	Notice (Other) (Exhibit 2) (30) Docket Text: NOTICE of Subpoenas on SRI International by Amgen Inc., Amgen Manufacturing, Limited (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine)
Sep 28, 2020	172	Subpoena Returned Executed (2) Docket Text: SUBPOENA Returned Executed as to Celerion, Inc. on September 28, 2020 (Mowery, Katharine)
Sep 28, 2020	173	Subpoena Returned Executed (2) Docket Text: SUBPOENA Returned Executed as to Celerion, Inc. on September 28, 2020 (Mowery, Katharine)
Sep 24, 2020	166	Order on Motion for Issuance of Letters Rogatory (2) Docket Text: ORDER granting [162] Motion for Issuance of Letters Rogatory. Signed by Judge Colm F. Connolly on 9/24/2020. (nmf)
Sep 24, 2020	167	Order on Motion for Issuance of Letters Rogatory (2) Docket Text: ORDER granting [163] Motion for Issuance of Letters Rogatory. Signed by Judge Colm F. Connolly on 9/24/2020. (nmf)
Sep 24, 2020	168	Order (10) Docket Text: Letter of Request for the Production of Documents and Examination of Witnesses in Croatia Pursuant to the Hague Convention re [166] Order on Motion for Issuance of Letters Rogatory. Signed by Judge Colm F. Connolly on 9/24/2020. (3 certified copies will be available in the Clerk's Office for pickup during the normal business hours of 8:30 a.m.-4:00 p.m.) (nmf)
Sep 24, 2020	169	Order (10) Docket Text: Letter of Request for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention re [167] Order on Motion for Issuance of Letters Rogatory. Signed by Judge Colm F. Connolly on 9/24/2020. (3 certified copies will be available in the Clerk's Office for pickup during the normal business hours of 8:30 a.m.-4:00 p.m.) (nmf)
Sep 17, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas P. Groombridge for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Sep 17, 2020	165	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [158] Letter, to The Honorable Christopher J. Burke from Arthur G. Connolly, III regarding Defendants' Opposition to Plaintiffs' Motion to Compel by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1)(Harper, Brandon)
Sep 17, 2020	165	Redacted Document (Exhibit 1) (8) Docket Text: REDACTED VERSION of [158] Letter, to The Honorable Christopher J. Burke from Arthur G. Connolly, III regarding Defendants' Opposition to Plaintiffs' Motion to Compel by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1)(Harper, Brandon)
Sep 16, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Peter Sandel for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Sep 15, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs Amgen Inc. and Amgen Manufacturing Limited's ("Plaintiffs" or "Amgen") discovery dispute motion ("Motion"), (D.I. [156]), in which Plaintiffs ask the Court to compel Defendants Hospira, Inc. and Pfizer Inc. ("Defendants" or "Pfizer") to produce seven documents that Defendants produced and then clawed back as part of a set of 37 documents that Defendants allege to be privileged, (D.I. 157 at 1), the parties' letter briefs relating thereto, (D.I. 157; D.I. 158), and having heard argument on September 14, 2020, hereby DENIES the Motion for the reasons that follow: (1) Having reviewed the content of the redacted portions of Documents 5-7, the Court agrees with Defendants that they are not relevant to the issues in this case, as they solely relate to an agreement between Pliva Croatia, Ltd. ("Pliva," the predecessors-in-interest to the Pfizer process) and Mayne Pharma PLC. (D.I. 158 at 2); (2) With regard to the remaining documents at issue, Documents 1-4, in addition to arguing that they are privileged, Defendants also assert that they are irrelevant to issues in the case. (D.I. 158 at 1) However, in light of the Court's decision below, it need not resolve this issue; instead, it will simply assume arguendo that these documents are relevant.; (3) Having reviewed the content of Documents 1 and 2, the Court agrees with Defendants that the entirety of their content is protected by the attorney-client privilege. (D.I. 158 at 2) The documents reflect legal advice regarding United States tax law provided by legal counsel to Pliva. The fact that such advice was relayed to other Pliva employees does not constitute a waiver of the attorney client privilege. See, e.g., INVISTA N. Am. S..r.l. v. M&G USA Corp., Civil Action No. 11-1007-SLR-CJB, 2013 WL 12171721, at 9 (D. Del. June 25, 2013). (4) Having reviewed the contents of Documents 3 and 4, the Court agrees with Defendants that the entirety of their content is protected by the attorney-client privilege. (D.I. 158 at 3) The memorandum that is part of the documents makes it clear that the documents describe the structure of a transaction for which Pliva has received legal advice from "Legal and Tax" and from its outside United States legal counsel. The Court agrees with Defendants that even to the extent that some portion of the documents reflect business and financial information relating to the transaction, "those factual issues are intertwined with the primary purpose of the memo, which is to relay legal advice regarding contract interpretation or negotiations." (D.I. 158 at 2); see, e.g., Immunex Corp. v. Sandoz Inc., Civil Action No. 16-1118 (CCC), 2017 WL 2466507, at 2, *4 (D.N.J. June 7, 2017). Ordered by Judge Christopher J. Burke on 9/15/2020. (mlc)
Sep 14, 2020	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery dispute teleconference held on 9/14/2020. The Court heard argument from the parties regarding Plaintiffs' discovery dispute, (D.I. 156), and took the matter under advisement. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: R. Whetzel, K. Mowery, N. Groombridge, J. Wu, P. Sandel, N. Werli for Plaintiffs; B. Harper, D. Driver, J. Phillips, B. Bone, E. Chang for Defendants. (mlc)
Sep 14, 2020	161	Letter (Main Document) (1) Docket Text: Letter to The Honorable Christopher J. Burke from Katharine L. Mowery regarding supplemental authority in support of its motion to compel production - re [157] Letter, [158] Letter,. (Attachments: # (1) Exhibit A)(Mowery, Katharine)
Sep 14, 2020	161	Letter (Exhibit A) (5) Docket Text: Letter to The Honorable Christopher J. Burke from Katharine L. Mowery regarding supplemental authority in support of its motion to compel production - re [157] Letter, [158] Letter,. (Attachments: # (1) Exhibit A)(Mowery, Katharine)
Sep 14, 2020	162	Motion for Issuance of Letters Rogatory (Main Document) (6) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Croatia Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	162	Motion for Issuance of Letters Rogatory (Text of Proposed Order) (2) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Croatia Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	162	Motion for Issuance of Letters Rogatory (Exhibit A) (30) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Croatia Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	162	Motion for Issuance of Letters Rogatory (Certificate of Compliance) (1) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Croatia Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	163	Motion for Issuance of Letters Rogatory (Main Document) (6) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	163	Motion for Issuance of Letters Rogatory (Text of Proposed Order) (2) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	163	Motion for Issuance of Letters Rogatory (Exhibit A) (30) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 14, 2020	163	Motion for Issuance of Letters Rogatory (Certificate of Compliance) (1) Docket Text: MOTION for Issuance of Letters Rogatory Plaintiffs' Unopposed Ex Parte Application for Issuance of Letter of Request for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance)(Mowery, Katharine)
Sep 11, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' letters regarding Plaintiffs' discovery dispute, (D.I. 157; D.I. 158), hereby ORDERS that Defendants shall submit the seven documents at issue to the Court in camera by emailing them to the Court's Courtroom Deputy, Ms. Benyo, by no later than 6:00pm on September 11, 2020. Ordered by Judge Christopher J. Burke on 9/22/2020. (dlb)
Sep 10, 2020	159	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [157] Letter by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-14, # (2) Text of Proposed Order, # (3) 7.1.1 Certification)(Mowery, Katharine)
Sep 10, 2020	159	Redacted Document (Exhibit 1-14) (14) Docket Text: REDACTED VERSION of [157] Letter by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-14, # (2) Text of Proposed Order, # (3) 7.1.1 Certification)(Mowery, Katharine)
Sep 10, 2020	159	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [157] Letter by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-14, # (2) Text of Proposed Order, # (3) 7.1.1 Certification)(Mowery, Katharine)
Sep 10, 2020	159	Redacted Document (7.1.1 Certification) (1) Docket Text: REDACTED VERSION of [157] Letter by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-14, # (2) Text of Proposed Order, # (3) 7.1.1 Certification)(Mowery, Katharine)
Aug 27, 2020	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' August 26, 2020 letter requesting a discovery teleconference regarding one discovery dispute. (D.I. 154) It hereby ORDERS as follows with regard to these disputes: (1) A discovery dispute teleconference is set for September 14, 2020 at 3:00 p.m. before Judge Christopher J. Burke.; (2) By no later than September 3, 2020, any party seeking relief shall file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issue in dispute and its position on that issue.; (3) By no later than September 10, 2020, any party opposing the application for relief may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining that party(s) reasons for its opposition.; (4) The moving party shall file the Motion For Teleconference To Resolve Discovery Dispute discussed in the Courts May 5, 2020 Oral Order. (D.I. 134); (5) By no later than September 10, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference and may, in that event, cancel the conference. Ordered by Judge Christopher J. Burke on 8/27/2020. (dlb)
Aug 27, 2020	156	Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Amgen Inc., Amgen Manufacturing, Limited. Motions referred to Christopher J. Burke.(Mowery, Katharine)
Aug 26, 2020	154	Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Katharine L. Mowery regarding Request for Discovery Dispute Teleconference. (Mowery, Katharine)
Aug 21, 2020	153	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brandon Ryan Harper on behalf of Hospira, Inc., Pfizer Inc. (Harper, Brandon)
Aug 7, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [152] Stipulation filed by Hospira, Inc., Pfizer Inc.. Signed by Judge Colm F. Connolly on 8/7/2020. (fms)
Aug 6, 2020	152	Stipulation (5) Docket Text: Joint STIPULATION to Amend Scheduling Order re [129] SO ORDERED,, Scheduling Order, by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Jul 27, 2020	151	Notice (Other) (1) Docket Text: NOTICE of Withdrawal of the Appearance of Ryan P. Newell as Counsel for Defendants Hospira, Inc. and Pfizer Inc. by Hospira, Inc., Pfizer Inc. (Newell, Ryan)
Jul 9, 2020	150	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Aaron J. Marks as co-counsel.. (Mowery, Katharine)
Jun 16, 2020	149	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jacob T. Whitt as co-counsel.. (Mowery, Katharine)
Jun 8, 2020	148	Transcript (25) Docket Text: Official Transcript of Telephone Conference held on June 3, 2020 before Judge Christopher J. Burke. Court Reporter Brian Gaffigan, Email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 6/29/2020. Redacted Transcript Deadline set for 7/9/2020. Release of Transcript Restriction set for 9/8/2020. (bpg)
Jun 3, 2020	N/A	Motion Hearing (0) Docket Text: Telephonic Motion Hearing held on 6/3/2020 regarding D.I. [137] MOTION for Protective Order filed by Hospira, Inc., Pfizer Inc. The Court heard argument from the parties regarding the protective order dispute. The court reporter was having connection issues, but the parties did not object to continuing with the teleconference. The Court will issue an order resolving the dispute. (Court Reporter Brian Gaffigan. Clerk: M. Crawford) Appearances: K. Mowery, R. Whetzel, N. Groombridge, J. Wu and A. Marks for Plaintiffs; A. Connolly, D. Drivas, S. Riley, A. Hanstead and K. Georgek for Defendants.
Jun 3, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered Defendants Hospira, Inc. and Pfizer Inc.'s ("Pfizer") protective order dispute motion, ("Motion"), (D.I. [137]), in which Pfizer asks the Court to enter a Protective Order forbidding Plaintiffs Amgen Inc. and Amgen Manufacturing, Limited ("Amgen") from disclosing Pfizer's Confidential Information to Amgen's expert Dr. Harvey Blanch, (D.I. 138 at 1), the parties' letter briefs relating thereto, (D.I. 138; D.I. 139), and having heard argument on June 3, 2020, hereby ORDERS that the Motion is DENIED for the following reasons: (1) The relevant Scheduling Order here allows for the filing of "supplemental" expert reports regarding Pfizer's on-sale bar and public use invalidity theories, (D.I. 129 at 2), but it does not indicate that this means that Amgen could not use an expert for such reports who has not previously opined on an issue in this case. It seems much more likely, as Amgen says, that "supplemental" was meant to mean "limited to on-sale bar/public use issues[.]" (D.I. 139 at 2); (2) The entire premise for this additional period of discovery is that Pfizer violated the spirit of the case schedule by late disclosing its on-sale bar invalidity theory. (D.I. 139, ex. A at 44-46) It would thus seem at odds with the nature of the District Court's decision there (which permitted Amgen to get "the discovery [it] need[s]") to prohibit Amgen from utilizing the the expert of its choice during this supplemental process. (Id. at 46); (3) Amgen promises that Dr. Blanch will not give duplicative testimony to that of its other experts or attempt to retreat from those experts' opinions. (D.I. 139 at 1-2) And since Amgen has not yet submitted a supplemental report from Dr. Blanch, there is no basis to believe Dr. Blanch would do otherwise.; (4) Pfizer's assertions that divulging its Confidential Information to another expert would cause a security risk are halfhearted, and the existence of the Protective Order should assuage any concerns there. (Id. at 3); and (5) If, in light of this Court's decision, Pfizer seeks some alteration of the dates in the relevant schedule, it should meet and confer with Amgen about such requests. Ordered by Judge Christopher J. Burke on 6/3/2020. (mlc)
Jun 2, 2020	146	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
Jun 2, 2020	146	Redacted Document (Exhibit A) (8) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
Jun 2, 2020	146	Redacted Document (Exhibit B) (4) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
Jun 2, 2020	146	Redacted Document (Exhibit E) (9) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
Jun 2, 2020	146	Redacted Document (Exhibit G) (30) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
Jun 2, 2020	146	Redacted Document (Exhibit H) (30) Docket Text: REDACTED VERSION of [139] Letter to The Honorable Christopher J. Burke from Robert W. Whetzel regarding Opposition to Plaintiffs' Motion for Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit E, # (4) Exhibit G, # (5) Exhibit H)(Whetzel, Robert)
May 29, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED D.I. [144] STIPULATION TO EXTEND TIME the public version of the Plaintiffs' Letter Brief in Opposition to Defendants' Motion for Protective Order and Exhibits A, B, E, G and H to June 2, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited. Ordered by Judge Christopher J. Burke on 5/29/2020. (mlc)
May 29, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court, having not received dial-in information from the parties regarding the protective order dispute teleconference scheduled for June 1, 2020 at 2:00 pm, despite repeated requests, hereby ORDERS that the teleconference is cancelled. The Court will resolve the dispute on the papers.Ordered by Judge Christopher J. Burke on 5/29/2020. (mlc)
May 28, 2020	144	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the public version of the Plaintiffs' Letter Brief in Opposition to Defendants' Motion for Protective Order and Exhibits A, B, E, G and H to June 2, 2020 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
May 26, 2020	142	Redacted Document (2) Docket Text: REDACTED VERSION of [137] MOTION for Protective Order by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
May 26, 2020	143	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [138] Letter, to Magistrate Judge Christopher Burke from Arthur G. Connolly, III regarding Letter Brief in Support of Defendants' Motion for a Protective Order by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1 to 13)(Riley, Stephanie)
May 26, 2020	143	Redacted Document (Exhibit 1 to 13) (30) Docket Text: REDACTED VERSION of [138] Letter, to Magistrate Judge Christopher Burke from Arthur G. Connolly, III regarding Letter Brief in Support of Defendants' Motion for a Protective Order by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit 1 to 13)(Riley, Stephanie)
May 22, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED D.I. [141] STIPULATION TO EXTEND TIME for Defendants to file Redacted Version of Motion for Protective Order, the Letter to Magistrate Judge Christopher J. Burke from Arthur G. Connolly, III Regarding Letter Brief in Support of Defendants' Motion for a Prot filed by Hospira, Inc., Pfizer Inc.. Ordered by Judge Christopher J. Burke on 5/22/2020. (mlc)
May 21, 2020	140	Exhibit to a Document (Main Document) (2) Docket Text: EXHIBIT re [139] Letter Exhibits C, D, F, I to Plaintiffs' May 21, 2020 Letter Brief to The Honorable Christopher J. Burke in Opposition to Defendants' Motion for a Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit C, D, F, I)(Whetzel, Robert)
May 21, 2020	140	Exhibit to a Document (Exhibit C, D, F, I) (22) Docket Text: EXHIBIT re [139] Letter Exhibits C, D, F, I to Plaintiffs' May 21, 2020 Letter Brief to The Honorable Christopher J. Burke in Opposition to Defendants' Motion for a Protective Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit C, D, F, I)(Whetzel, Robert)
May 21, 2020	141	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to file Redacted Version of Motion for Protective Order, the Letter to Magistrate Judge Christopher J. Burke from Arthur G. Connolly, III Regarding Letter Brief in Support of Defendants' Motion for a Protective Order, and Exhibits 1 to 13 to May 26, 2020 - filed by Hospira, Inc., Pfizer Inc.. (Riley, Stephanie)
May 7, 2020	135	Motion for Hearing (Main Document) (2) Docket Text: Joint MOTION for Hearing re [134] Oral Order,,,,, to Resolve Protective Order Dispute - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Joint Letter Requesting Teleconference Regarding Protective Order Dispute)Motions referred to Christopher J. Burke.(Connolly, Arthur)
May 7, 2020	135	Motion for Hearing (Joint Letter Requesting Teleconference Regarding Protective Order Dispute) (3) Docket Text: Joint MOTION for Hearing re [134] Oral Order,,,,, to Resolve Protective Order Dispute - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Joint Letter Requesting Teleconference Regarding Protective Order Dispute)Motions referred to Christopher J. Burke.(Connolly, Arthur)
May 7, 2020	N/A	Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER setting protective order dispute teleconference: The Court, having reviewed the parties' joint letter regarding a protective order dispute, (D.I. 135, ex. 1), hereby ORDERS that the procedures for resolving a protective order dispute set out in the Scheduling Order, (D.I. 26), shall be modified as follows: (1) A protective order dispute teleconference will be held on June 1, 2020 at 2:00 PM before Judge Christopher J. Burke; (2) By May 14, 2020, the moving parties shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and their position on those issues.; (3) By May 21, 2020, the responding parties may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their response to the moving parties initial letter.; and (4) The Court may choose to resolve the dispute on the papers prior to the teleconference. If it does so, it will thereafter cancel the teleconference. Ordered by Judge Christopher J. Burke on 5/7/2020. (dlb)
May 5, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the case history in light of the May 4, 2020 referral, hereby ORDERS that the procedures for resolving a dispute relating to discovery or the protective order set out in the Scheduling Order, (D.I. 26 at 6), will be modified as follows: Should counsel find, after good faith efforts including verbal communication among Delaware and Lead Counsel for all parties to the dispute, that they are unable to resolve a discovery or protective order matter, the parties involved in the dispute shall submit a joint letter with the text set out in the Court's standard Rule 16 Scheduling Order for Patent cases, which can be found in the "Forms" tab of Magistrate Judge Burke's page on the District Court's website. For disputes relating to discovery, the moving party (i.e., the party seeking relief from the Court) should also file a Motion For Teleconference To Resolve Discovery Dispute, and for disputes relating to protective orders, the parties shall file a Joint Motion for Teleconference to Resolve Protective Order Dispute. The suggested text for these motions can be found in the same Forms tab. The Court will thereafter set a discovery or protective order dispute telephone conference. Ordered by Judge Christopher J. Burke on 5/5/2020. (dlb)
May 4, 2020	133	Order Referring Case to Magistrate Judge (1) Docket Text: ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke for all disputes relating to discovery and the protective order. Signed by Judge Colm F. Connolly on 5/4/2020. (nmf)
Apr 8, 2020	132	Order Setting Mediation Conferences (7) Docket Text: ORAL ORDER Setting Mediation Conferences: A Telephonic Mediation Conference is set for 5/13/2020 at 10:00 AM Eastern Time with Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 4/8/20. (cak)
Apr 2, 2020	131	Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Brendan Gavin as Co-Counsel by Hospira, Inc., Pfizer Inc. (Riley, Stephanie)
Mar 27, 2020	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 4/1/2020 at 11:30 AM Eastern Time with Judge Mary Pat Thynge. Ordered by Judge Mary Pat Thynge on 3/27/20. (cak)
Feb 18, 2020	129	SO ORDERED (5) Docket Text: SO ORDERED, re [128] STIPULATION TO AMEND THE SCHEDULING ORDER. SCHEDULING ORDER: Dispositive Motions due by 2/17/2021., Proposed Pretrial Order, Proposed Jury Instructions, Voir Dire and Special Verdict Form due by 4/8/2021., A Final Pretrial Conference is set for 5/6/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly., A Jury Trial is set for 5/17/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/18/2020. (nmf)
Feb 14, 2020	128	Stipulation (5) Docket Text: Joint STIPULATION to Amend Scheduling Order with Proposed Order by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Jan 31, 2020	127	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 21-30) filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Jan 24, 2020	126	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Responses & Objections to Amgen's Fourth Set of Requests for Production of Documents (Nos. 66-162) filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Jan 23, 2020	124	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Alois Jungbauer on January 28, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 23, 2020	125	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Carl Scandella on February 6, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 17, 2020	119	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ryan Sullivan, Ph.D. on February 11, 2020 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 17, 2020	120	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Barry Rosenblatt, Ph.D. on February 4, 2020 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 17, 2020	121	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Andrew Zydney, Ph.D. on February 5, 2020 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 17, 2020	122	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jonathan D. Putnam on January 22, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 17, 2020	123	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Todd Pryzbycien on January 24, 2020 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 16, 2020	118	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Reply Expert Report of Todd M Przybycien, Ph.D. and Defendants' Reply Expert Report of Alois Jungbauer, Ph.D. filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 15, 2020	117	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Barry Rosenblatt, Ph.D. Regarding Infringement by Pfizer of U.S. Patent No. 9,643,997; Reply Expert Report of Andrew Zydney, Ph.D. Regarding Infringement by Pfizer of U.S. Patent No. 9,643,997; and Reply Report of Ryan Sullivan, Ph.D. filed by Amgen Inc., Amgen Manufacturing, Limited.(Cragg, Tyler)
Jan 8, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Elizabeth Chang for Hospira, Inc.,Elizabeth Chang for Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Dec 20, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [115] MOTION for Pro Hac Vice Appearance of Attorney Elizabeth Chang filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 12/20/2019. (fms)
Dec 20, 2019	115	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elizabeth Chang - filed by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Dec 20, 2019	116	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Second Set of Interrogatories (Nos. 21-30); Amgen's Fourth Set of Requests for Production (Nos. 66-161); and Amgen's E-Discovery Supplemental Custodians and Search Terms filed by Amgen Inc., Amgen Manufacturing, Limited.(Cragg, Tyler)
Dec 18, 2019	113	Notice of Service (2) Docket Text: NOTICE OF SERVICE of the Responsive Expert Report of Barry Rosenblatt, Ph.D. regarding Validity of U.S. Patent No. 9,643,997 filed by Amgen Inc., Amgen Manufacturing, Limited.(Cragg, Tyler)
Dec 18, 2019	114	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Rebuttal Expert Report of Carl Scandella, Ph.D. and (2) Defendants' Expert Rebuttal Report of Jonathan D. Putnam filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Dec 10, 2019	107	Redacted Document (Main Document) (12) Docket Text: REDACTED VERSION of [102] Letter,, to The Honorable Colm F. Connolly from Arthur G. Connolly, III regarding Defendants' Letter Brief In Support of Their Motion to Strike Portions of Plaintiffs' Infringement Contentions Regarding U.S. Patent No. 9,643,997 and Expert Reports Applying a New Claim Construction with 7.1.1 Certification, Proposed Order, Certificate of Compliance, and Certificate of Service - re 101 MOTION to Strike Portions of Plaintiffs' Infringement Contentions Regarding U.S. Patent No. 9,643,997 and Expert Reports Applying a New Claim Construction by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) [REDACTED] Exhibits 1-8)(Riley, Stephanie)
Dec 10, 2019	107	Redacted Document ([REDACTED] Exhibits 1-8) (30) Docket Text: REDACTED VERSION of [102] Letter,, to The Honorable Colm F. Connolly from Arthur G. Connolly, III regarding Defendants' Letter Brief In Support of Their Motion to Strike Portions of Plaintiffs' Infringement Contentions Regarding U.S. Patent No. 9,643,997 and Expert Reports Applying a New Claim Construction with 7.1.1 Certification, Proposed Order, Certificate of Compliance, and Certificate of Service - re 101 MOTION to Strike Portions of Plaintiffs' Infringement Contentions Regarding U.S. Patent No. 9,643,997 and Expert Reports Applying a New Claim Construction by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) [REDACTED] Exhibits 1-8)(Riley, Stephanie)
Dec 10, 2019	108	Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [105] Letter, to The Honorable Colm F. Connolly from Arthur G. Connolly, III regarding Defendants' Opposition to Plaintiffs' Motion to Strike and Preclude Defendants' On-Sale/Public Use Invalidity Theory with Certificate of Comp liance and Certificate of Service - re 104 Letter, 103 MOTION to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory. by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) [REDACTED] Exhibits 1-8)(Riley, Stephanie)
Dec 10, 2019	108	Redacted Document ([REDACTED] Exhibits 1-8) (30) Docket Text: REDACTED VERSION of [105] Letter, to The Honorable Colm F. Connolly from Arthur G. Connolly, III regarding Defendants' Opposition to Plaintiffs' Motion to Strike and Preclude Defendants' On-Sale/Public Use Invalidity Theory with Certificate of Comp liance and Certificate of Service - re 104 Letter, 103 MOTION to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory. by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) [REDACTED] Exhibits 1-8)(Riley, Stephanie)
Dec 10, 2019	109	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Second Supplemental Objections and Responses to Defendants' Interrogatory No. 8 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Dec 10, 2019	110	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [103] MOTION to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order)(Mowery, Katharine)
Dec 10, 2019	110	Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [103] MOTION to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order)(Mowery, Katharine)
Dec 10, 2019	111	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [104] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Plaintiff's Letter Brief in Support of Motion to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-13, # (2) Certificate of Compliance, # (3) Averment of Counsel)(Mowery, Katharine)
Dec 10, 2019	111	Redacted Document (Exhibit 1-13) (30) Docket Text: REDACTED VERSION of [104] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Plaintiff's Letter Brief in Support of Motion to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-13, # (2) Certificate of Compliance, # (3) Averment of Counsel)(Mowery, Katharine)
Dec 10, 2019	111	Redacted Document (Certificate of Compliance) (2) Docket Text: REDACTED VERSION of [104] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Plaintiff's Letter Brief in Support of Motion to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-13, # (2) Certificate of Compliance, # (3) Averment of Counsel)(Mowery, Katharine)
Dec 10, 2019	111	Redacted Document (Averment of Counsel) (2) Docket Text: REDACTED VERSION of [104] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Plaintiff's Letter Brief in Support of Motion to Strike and Preclude Defendants' New On-Sale/Public Use Invalidity Theory by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-13, # (2) Certificate of Compliance, # (3) Averment of Counsel)(Mowery, Katharine)
Dec 10, 2019	112	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [106] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding responsive letter brief in opposition to defendants' motion to strike by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-11)(Mowery, Katharine)
Dec 10, 2019	112	Redacted Document (Exhibit 1-11) (30) Docket Text: REDACTED VERSION of [106] Letter, to The Honorable Colm F. Connolly from Robert W. Whetzel regarding responsive letter brief in opposition to defendants' motion to strike by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-11)(Mowery, Katharine)
Dec 6, 2019	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 12/6/2019. (Court Reporter V. Gunning.) (nmf)
Dec 5, 2019	N/A	Oral Order (0) Docket Text: ORAL ORDER Resetting Hearings: Due to a conflict in the Court's schedule, the Discovery Conference on 12/6/2019 is rescheduled to begin at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 12/5/2019. (nmf)
Nov 13, 2019	100	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rule of Civil Procedure and the Delaware Default Standard of Discovery filed by Hospira, Inc., Pfizer Inc..(Riley, Stephanie)
Nov 7, 2019	99	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Reports of Andrew Zydney, Ph.D., Barry Rosenblatt, Ph.D. and Ryan Sullivan, Ph.D. filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Nov 6, 2019	98	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Expert Report of Todd M. Przybycien, Ph.D. with Exhibits 1 and 2 and Defendants' Expert Report of Alois Jungbauer, Ph.D. with Exhibits 1 and 2 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Nov 5, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric M. Agovino, Kimberlin L. Morley for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam)
Nov 1, 2019	N/A	Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 12/6/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. (nmf)
Oct 31, 2019	97	SO ORDERED (5) Docket Text: SO ORDERED, re [96] Stipulation filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 10/31/2019. (fms)
Oct 30, 2019	96	Stipulation (5) Docket Text: STIPULATION Re: Witnesses Disclosed Prior to Trial by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Oct 15, 2019	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the Notice of Service at D.I. [95] has been replaced with a corrected version including counsel's signature per request of filer. (nmf)
Oct 14, 2019	95	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions and Supplemental Responses to Plaintiff's First Set of Interrogatories filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur) (Main Document 95 replaced on 10/15/2019) (nmf, ).
Oct 11, 2019	94	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) [Confidential] Amgen's First Supplemental Disclosure of Asserted Claims and Infringement Contentions; (2) [Confidential] Amgen's First Supplemental Objections and Responses to Defendants' Interrogatory Nos. 8, 11-12, 14, 16-19, 23; and (3) [Confidential] Amgen's First Supplemental Objections and Responses to Defendants' First Set of Requests for Admission Nos. 6, 15 filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Sep 27, 2019	92	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and the Delaware Default Standard for Discovery filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 27, 2019	93	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Joseph Edward Schultz (First Amended) on mutually agreeable day filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 25, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [91] STIPULATION TO EXTEND TIME for parties to serve supplemental responses to interrogatories and supplemental contentions to October 11, 2019 filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 9/25/2019. (fms)
Sep 24, 2019	91	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for parties to serve supplemental responses to interrogatories and supplemental contentions to October 11, 2019 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Sep 9, 2019	87	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Christophe Bourdon on September 23, 2019 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 9, 2019	88	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Linda Louie on September 25, 2019 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 9, 2019	89	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Tara Arvedson on September 19, 2019 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 9, 2019	90	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Roger Hart on October 4, 2019 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Sep 5, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [85] STIPULATION to Extend Time regarding scheduling deadlines. Signed by Judge Colm F. Connolly on 9/5/2019. (nmf)
Sep 5, 2019	86	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Stephanie S. Riley on behalf of Hospira, Inc., Pfizer Inc. (Riley, Stephanie)
Sep 4, 2019	85	Stipulation (3) Docket Text: STIPULATION to Extend Time regarding scheduling deadlines by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Aug 26, 2019	84	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses to Amgen's First Set of Interrogatories filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Aug 23, 2019	83	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Amgens Objections and Responses to Defendants Third Set of Requests for Production (Nos. 62-76); (2) Amgens Objections and Responses to Defendants First Set of Requests for Admission (Nos. 1-20); and (3) Amgens Objections and Responses to Defendants Second Set of Interrogatories to Plaintiffs (Nos. 11-23) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Aug 22, 2019	82	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses to Plaintiffs' Third Requests for Production re [69] Notice of Service filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Aug 20, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [81] STIPULATION TO EXTEND TIME for various deadlines in the Scheduling Order (D.I. 26) to multiple dates filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 8/20/2019. (nmf)
Aug 19, 2019	78	Notice (Other) (2) Docket Text: Amended NOTICE of Video Deposition of Elizabeth Burns on September 27, 2019 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Aug 19, 2019	79	Notice (Other) (2) Docket Text: Amended NOTICE of Video Deposition of Goran Valinger on September 19, 2019 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Aug 19, 2019	80	Notice (Other) (2) Docket Text: Amended NOTICE of Video Deposition of Neeti Arora on September 5, 2019 by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Aug 19, 2019	81	Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for various deadlines in the Scheduling Order (D.I. 26) to multiple dates - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Aug 12, 2019	77	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notices of Deposition for Raymond Doss and Patricia Hua filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Aug 6, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [74] MOTION for Pro Hac Vice Appearance of Attorney Peter Sandel filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 8/6/2019. (fms)
Aug 6, 2019	76	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amended Notice of Deposition of Roger Hart re [66] Notice of Service filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Aug 2, 2019	75	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Cisio De Oliveria Brandao on August 13, 2019 filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jul 31, 2019	74	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter Sandel - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Jul 26, 2019	71	Notice (Other) (2) Docket Text: NOTICE of Video Deposition of Elizabeth Burns by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Jul 26, 2019	72	Notice (Other) (2) Docket Text: NOTICE of Video Deposition of Goran Valinger by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Jul 26, 2019	73	Notice (Other) (2) Docket Text: NOTICE of Video Deposition of Neeti Arora by Amgen Inc., Amgen Manufacturing, Limited (Mowery, Katharine)
Jul 24, 2019	70	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Second Set of Interrogatories to Plaintiffs (Nos. 11-23) (2) Defendants' First Set of Requests for Admission to Plaintiffs and (3) Defendants' Third Set of Requests for Production (Nos. 62-76) filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jul 23, 2019	69	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's: (1) First Set of Interrogatories (Nos. 1-20); and (2) Third Set of Requests for Production (Nos. 62-65) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jul 22, 2019	68	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Rule 30(b)(6) Deposition filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jul 16, 2019	67	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Notice of Video Deposition of Hospira, Inc. and Pfizer Inc. Pursuant to Federal Rule of Civil Procedure Rule 30(b)(6) re [63] Notice of Service filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jul 1, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paula S. Fritsch for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jul 1, 2019	66	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Notice of Deposition of Roger Hart; (2) Notice of Deposition of Joseph Edward Shultz; (3) Notice of Rule 30(b)(6) Deposition of Plaintiffs re [1] Complaint, filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jun 28, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [65] MOTION for Pro Hac Vice Appearance of Attorney Paula Fritsch filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 6/28/2019. (nmf)
Jun 28, 2019	65	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paula Fritsch - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Jun 24, 2019	64	Transcript (87) Docket Text: Official Transcript of Markman hearing held on May 15, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/15/2019. Redacted Transcript Deadline set for 7/25/2019. Release of Transcript Restriction set for 9/23/2019. (vjg)
Jun 20, 2019	62	Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery Including Discovery Of Electronically Sotred Information filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jun 20, 2019	63	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Video Deposition of Hospira, Inc. and Pfizer, Inc. filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
May 30, 2019	61	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Stephen A. Maniscalco as co-counsel.. (Mowery, Katharine)
May 24, 2019	60	Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Amended Initial Disclosures filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
May 20, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron J. Marks for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
May 17, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [59] MOTION for Pro Hac Vice Appearance of Attorney Aaron J. Marks filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 5/17/2019. (fms)
May 16, 2019	59	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron J. Marks - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
May 15, 2019	N/A	Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 5/15/2019. (Court Reporter V. Gunning.) (nmf)
May 9, 2019	58	Notice (Other) (Main Document) (3) Docket Text: NOTICE of Subsequent Authority by Hospira, Inc., Pfizer Inc. re [55] Claim Construction Opening Brief (Attachments: # (1) Exhibit A (Appeal No. 18-1551 Judgment), # (2) Exhibit B (Appeal No. 18-1551 Opinion))(Connolly, Arthur)
May 9, 2019	58	Notice (Other) (Exhibit A (Appeal No. 18-1551 Judgment)) (3) Docket Text: NOTICE of Subsequent Authority by Hospira, Inc., Pfizer Inc. re [55] Claim Construction Opening Brief (Attachments: # (1) Exhibit A (Appeal No. 18-1551 Judgment), # (2) Exhibit B (Appeal No. 18-1551 Opinion))(Connolly, Arthur)
May 9, 2019	58	Notice (Other) (Exhibit B (Appeal No. 18-1551 Opinion)) (17) Docket Text: NOTICE of Subsequent Authority by Hospira, Inc., Pfizer Inc. re [55] Claim Construction Opening Brief (Attachments: # (1) Exhibit A (Appeal No. 18-1551 Judgment), # (2) Exhibit B (Appeal No. 18-1551 Opinion))(Connolly, Arthur)
Apr 25, 2019	57	Answer to Counterclaim (7) Docket Text: ANSWER to [51] Answer to Amended Complaint, Counterclaim by Amgen Inc., Amgen Manufacturing, Limited.(Whetzel, Robert)
Apr 22, 2019	54	SO ORDERED (3) Docket Text: SO ORDERED, re [53] STIPULATION and [Proposed] Order Regarding Joint Claim Construction Brief: Joint Claim Construction Brief due by 4/22/2019. Signed by Judge Colm F. Connolly on 4/19/2019. (nmf)
Apr 22, 2019	55	Claim Construction Opening Brief (30) Docket Text: Joint CLAIM CONSTRUCTION OPENING BRIEF filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Apr 22, 2019	56	Appendix (Main Document) (4) Docket Text: Joint APPENDIX re [55] Claim Construction Opening Brief by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-10)(Mowery, Katharine)
Apr 22, 2019	56	Appendix (Exhibit 1-10) (30) Docket Text: Joint APPENDIX re [55] Claim Construction Opening Brief by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-10)(Mowery, Katharine)
Apr 18, 2019	53	Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Joint Claim Construction Brief by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Apr 15, 2019	52	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (a) Defendants' Sur-Reply Claim Construction Brief, (b) Defendants' revised Answering Claim Construction Brief, and (c) revised Declaration of Todd M. Przybycien, Ph.D. in Support of Defendants' Answering Claim Construction Brief filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Apr 11, 2019	51	Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [49] Amended Complaint , COUNTERCLAIM against All Plaintiffs by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Apr 3, 2019	50	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Reply Claim Construction Brief filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Mar 29, 2019	48	Order on Motion for Leave to File (1) Docket Text: ORDER granting [45] Motion for Leave to File. Signed by Judge Colm F. Connolly on 3/28/2019. (fms)
Mar 29, 2019	49	Amended Complaint (30) Docket Text: FIRST AMENDED AND SUPPLEMENTAL COMPLAINT against Hospira, Inc., Pfizer Inc.- filed by Amgen Inc., Amgen Manufacturing, Limited.(fms)
Mar 25, 2019	47	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Objections and Responses to Defendants': (1) Second Set of Requests for Production (Nos. 51-61); and (2) First Set of Interrogatories to Plaintiffs (Nos. 1-10) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Mar 22, 2019	45	Motion for Leave to File (Main Document) (3) Docket Text: MOTION for Leave to File an Amended and Supplemental Complaint [Unopposed] - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B)(Whetzel, Robert)
Mar 22, 2019	45	Motion for Leave to File (Text of Proposed Order) (1) Docket Text: MOTION for Leave to File an Amended and Supplemental Complaint [Unopposed] - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B)(Whetzel, Robert)
Mar 22, 2019	45	Motion for Leave to File (Exhibit A) (30) Docket Text: MOTION for Leave to File an Amended and Supplemental Complaint [Unopposed] - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B)(Whetzel, Robert)
Mar 22, 2019	45	Motion for Leave to File (Exhibit B) (23) Docket Text: MOTION for Leave to File an Amended and Supplemental Complaint [Unopposed] - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B)(Whetzel, Robert)
Mar 22, 2019	46	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Hospira, Inc. and Pfizer, Inc.'s Answering Claim Construction Brief with Exhibits filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Mar 1, 2019	44	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Opening Claim Construction Brief filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Feb 28, 2019	43	Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur)
Feb 22, 2019	41	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Second Set of Requests for Production of Documents re [37] Notice of Service filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Feb 22, 2019	42	Notice (Other) (2) Docket Text: NOTICE of Defendants' Second Set of Request for Production (51-61) and Defendants' First Set of Interrogatories (1-10) by Hospira, Inc., Pfizer Inc. (Connolly, Arthur)
Feb 15, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brendan A. Gavin for Hospira, Inc., Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
Feb 8, 2019	40	Claim Construction Chart (Main Document) (2) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-2)(Mowery, Katharine)
Feb 8, 2019	40	Claim Construction Chart (Exhibit 1-2) (30) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-2)(Mowery, Katharine)
Jan 25, 2019	38	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Preliminary List of Claim Terms for Construction and Proposed Constructions filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 25, 2019	39	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Initial Proposed Claim Constructions filed by Hospira, Inc., Pfizer Inc..(Connolly, Arthur)
Jan 22, 2019	37	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Second Set of Requests for Production (Nos. 54-61) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Jan 16, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brigid Bone for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
Jan 15, 2019	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin J. Georgek for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Jan 14, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [34] MOTION for Pro Hac Vice Appearance of Attorney Brendan Gavin, Kevin Georgek, and Brigid Bone filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 1/14/2019. (fms)
Jan 14, 2019	36	Notice (Other) (2) Docket Text: NOTICE of Service of Defendants' Initial Invalidity Contentions by Hospira, Inc., Pfizer Inc. (Connolly, Arthur)
Jan 11, 2019	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, D.I. [35] has been removed and replaced with a version that has a corrected signature line. (fms)
Jan 11, 2019	34	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brendan Gavin, Kevin Georgek, and Brigid Bone - filed by Hospira, Inc., Pfizer Inc.. (Connolly, Arthur)
Jan 11, 2019	35	Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Amit Thakore as Co-Counsel for Defendants by Hospira, Inc., Pfizer Inc. (Connolly, Arthur) (Main Document 35 replaced on 1/11/2019) (fms).
Jan 7, 2019	32	Protective Order (27) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 1/7/2019. (fms)
Jan 7, 2019	33	Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel by Hospira, Inc., Pfizer Inc. for Mary I. Akhimien, Esquire (Akhimien, Mary)
Jan 4, 2019	31	Proposed Order (27) Docket Text: PROPOSED ORDER [Stipulated Protective Order] by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Dec 20, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [29] STIPULATION TO EXTEND TIME to extend the deadlines for parties to submit a proposed protective order to January 8, 2019 filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 12/20/2018. (fms)
Dec 20, 2018	29	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to extend the deadlines for parties to submit a proposed protective order to January 8, 2019 - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Dec 20, 2018	30	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Requests for Production filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Dec 14, 2018	28	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosure of Asserted Claims and Infringement Contentions filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Dec 6, 2018	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
Dec 6, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer H. Wu,Jacob T. Whitt,Naz Erdeniz Wehrli,Jennifer Gordon,Stephen A. Maniscalco for Amgen Inc., Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Dec 6, 2018	26	Scheduling Order (14) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/22/2019. Amended Pleadings due by 3/22/2019. Fact Discovery completed by 8/23/2019. Dispositive Motions due by 2/14/2020. Joint Claim Construction Brief due by 4/18/2019. A Markman Hearing is set for 5/15/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 6/2/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 6/15/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/6/2018. (nmf)
Dec 6, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before Thursday, December 20, 2018, by email to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, as well as opposing counsel, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. Ordered by Chief Magistrate Judge Mary Pat Thynge on 12/06/18. (cak) (cak)
Dec 4, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Jacob T. Whitt and Stephen A. Maniscalco filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 12/4/2018. (fms)
Dec 3, 2018	25	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jacob T. Whitt and Stephen A. Maniscalco - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Nov 30, 2018	21	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's Initial Disclosures and Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Nov 30, 2018	22	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Mary I. Akhimien on behalf of Hospira, Inc., Pfizer Inc. (Akhimien, Mary)
Nov 30, 2018	23	Proposed Order (Main Document) (14) Docket Text: PROPOSED ORDER re: Scheduling Order [Patent Case] by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Whetzel, Robert)
Nov 30, 2018	23	Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER re: Scheduling Order [Patent Case] by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Whetzel, Robert)
Nov 30, 2018	24	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures filed by Hospira, Inc., Pfizer Inc..(Akhimien, Mary)
Nov 27, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER, Whereas the Court directed the parties during the October 31, 2018 hearing to file a proposed scheduling order using the Court's form order and whereas the parties have not done so, it is hereby ORDERED that the parties shall file by no later than November 30, 2018 a proposed scheduling order using the Court's form order (revised as of November 14, 2018). Ordered by Judge Colm F. Connolly on 11/27/2018. (nmf)
Nov 27, 2018	20	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' 1st Set of Requests for Production of Documents re [16] Notice of Service filed by Hospira, Inc., Pfizer Inc..(Akhimien, Mary)
Nov 21, 2018	19	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for Production (Nos. 1-50) filed by Hospira, Inc., Pfizer Inc..(Akhimien, Mary)
Oct 31, 2018	N/A	Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 10/31/2018. (Court Reporter V. Gunning.) Counsel to submit a Word version of the revised proposed scheduling order to the Court. (nmf)
Oct 30, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [18] MOTION for Pro Hac Vice Appearance of Attorney Nicholas p. Groombridge, Jennifer H. Wu, Jennifer Gordon and Naz Erdeniz filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 10/30/2018. (fms)
Oct 29, 2018	17	Proposed Order (Main Document) (13) Docket Text: PROPOSED ORDER Re: Scheduling Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit enclosure letter to the Court)(Whetzel, Robert)
Oct 29, 2018	17	Proposed Order (Exhibit enclosure letter to the Court) (1) Docket Text: PROPOSED ORDER Re: Scheduling Order by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit enclosure letter to the Court)(Whetzel, Robert)
Oct 29, 2018	18	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas p. Groombridge, Jennifer H. Wu, Jennifer Gordon and Naz Erdeniz - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine)
Oct 26, 2018	16	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amgen's First Set of Requests for Production (Nos. 1-53) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine)
Oct 12, 2018	15	Order Setting Scheduling Conference (1) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 10/31/2018 at 10:00 AM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 10/11/2018. (nmf)
Oct 3, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: In light of the reassignment of this case, the Court HEREBY ORDERS that the prior referral to Chief Magistrate Judge Mary Pat Thynge is withdrawn, with the exception that any referral to a Magistrate Judge for ADR shall remain in place. Ordered by Judge Colm F. Connolly on 10/3/2018. (nmf)
Aug 31, 2018	N/A	Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Aug 30, 2018	14	Answer to Counterclaim (7) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Amgen Inc., Amgen Manufacturing, Limited.(Whetzel, Robert)
Aug 24, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Mary Pat Thynge on 8/24/2018. (fms)
Aug 23, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amit H. Thakore,Dimitrios T. Drivas,John P. Scheibeler for Hospira, Inc., Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 23, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alison Hanstead for Hospira, Inc., Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 23, 2018	13	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford - filed by Amgen Inc., Amgen Manufacturing, Limited. Motions referred to Mary Pat Thynge.(Cragg, Tyler)
Aug 21, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore filed by Hospira, Inc., Pfizer Inc. Signed by Judge Mary Pat Thynge on 8/21/2018. (fms)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Main Document) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Proposed Order) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Certification of Dimitrios T. Drivas) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Certification of John Scheibeler) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Certification of Alison Hanstead) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 21, 2018	12	Motion for Leave to Appear Pro Hac Vice (Certification of Amit Thakore) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John Scheibeler, Alison Hanstead, Amit Thakore - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Proposed Order, # (2) Certification of Dimitrios T. Drivas, # (3) Certification of John Scheibeler, # (4) Certification of Alison Hanstead, # (5) Certification of Amit Thakore)Motions referred to Mary Pat Thynge.(Connolly, Arthur)
Aug 15, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Eric Agovino and Kimberlin L. Morley filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Mary Pat Thynge on 8/15/2018. (fms)
Aug 14, 2018	11	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric Agovino and Kimberlin L. Morley - filed by Amgen Inc., Amgen Manufacturing, Limited. Motions referred to Mary Pat Thynge.(Cragg, Tyler)
Aug 10, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Douglas G. Bolesch,Mark H. Izraelewicz,Kevin M. Flowers,John R. Labbe for Amgen Inc., Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 9, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [7] MOTION for Pro Hac Vice Appearance of Attorney John R. Labbe, Kevin M. Flowers, Mark Izraelwicz and Doug Bolesch filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Mary Pat Thynge on 8/9/2018. (fms)
Aug 9, 2018	8	Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against Amgen Inc., Amgen Manufacturing, Limited by Pfizer Inc., Hospira, Inc..(Connolly, Arthur)
Aug 9, 2018	9	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Hospira, Inc.. (Connolly, Arthur)
Aug 9, 2018	10	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc.. (Connolly, Arthur)
Aug 8, 2018	7	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John R. Labbe, Kevin M. Flowers, Mark Izraelwicz and Doug Bolesch - filed by Amgen Inc., Amgen Manufacturing, Limited. Motions referred to Mary Pat Thynge.(Cragg, Tyler)
Jul 26, 2018	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The 7/26/2018 Case referred for mediation entry was entered on the docket in error and has been removed. (fms)
Jul 26, 2018	N/A	Remark (0) Docket Text: ***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynge's jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. � 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (fms)
Jul 25, 2018	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb)
Jul 25, 2018	N/A	Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb)
Jul 19, 2018	N/A	Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hospira, Inc. on 7/19/2018; Pfizer Inc. on 7/19/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs)
Jul 19, 2018	5	Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc., Amgen Manufacturing, Limited. Hospira, Inc. served on 7/19/2018, answer due 8/9/2018. (Whetzel, Robert)
Jul 19, 2018	6	Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc., Amgen Manufacturing, Limited. Pfizer Inc. served on 7/19/2018, answer due 8/9/2018. (Whetzel, Robert)
Jul 18, 2018	1	Complaint (Main Document) (18) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422031.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs)
Jul 18, 2018	1	Complaint (Exhibit A) (23) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422031.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs)
Jul 18, 2018	1	Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422031.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs)
Jul 18, 2018	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs)
Jul 18, 2018	3	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,643,997. (jcs)
Jul 18, 2018	4	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for Amgen Manufacturing, Limited. Amgen Inc. is a publicly held corporation and has no parent corporation. filed by Amgen Inc., Amgen Manufacturing, Limited. (jcs)
Jul 18, 2018	1	Complaint* (1)

Lawsuits

Amgen Inc. et al v. Hospira, Inc. et al > Documents